Bedford Laboratories Polymyxin B For Injection USP And Vecuronium Bromide For Injection: Recall - Glass Particles
Particulate matter in injections can be harmful when introduced into the bloodstream.
Endo Pharmaceuticals Opiate Products by Novartis Consumer Health: Public Health Advisory - Potential Safety Risk
A packaging problem may result in a pill, tablet or caplet getting mixed in with a different prescription.
Novartis Consumer Health Over-The-Counter Products: Recall - Potential Presence of Foreign Tablets or Chipped or Broken Tablets or Gelcaps
Consumers are asked to either destroy or return unused product identified in the recall to Novartis.
Ikaria INOmax DS Drug Delivery System: Class I Recall - Erratic Nitric Oxide (NO) Readings
Adverse consequences may include hypoxia, hypotension, bradycardia, cardiac arrest, organ damage, acute respiratory distress syndrome (ARDS), neurological deficits, or death.
CareFusion AVEA Ventilator: Recall - Failure May Lead to Lack of Ventilation
Ventilator may stop ventilating and result in life-threatening injury or death.
Liquid Acetaminophen marketed for infants: Drug Safety Communication - Potential for Dosing Errors
Additional concentration of liquid acetaminophen marketed for “infants” (160 mg/5 mL) is now available.
Eclectic Institute Dietary Supplements: Recall - Possible Salmonella Contamination
Salmonella can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems.
ShoulderFlex Massager: Warning - Risk of Strangulation
Hair, clothing or jewelry can become entangled in the ShoulderFlex Massager and cause serious injury or even death from strangulation.
St. Jude Medical, Riata and Riata ST Silicone Endocardial Defibrillation Leads: Class 1 Recall - Failures with Lead Insulation
Premature insulation abrasion may cause the conductors to become externalized, which can cause serious adverse health consequences, including death.
Gilenya (fingolimod): Drug Safety Communication - Safety Review of a Reported Death After the First Dose
Patients with MS should not stop taking Gilenya without talking to their healthcare professional.